跳至主要内容
临床试验/TCTR20240515007
TCTR20240515007尚未招募4 期

The improvement of neovaginal symptoms and microbiota in transgender women who received E3 and lactobacilli via vaginal suppository

Ratchadapiseksompotch fund0 个研究点目标入组 50 人开始时间: 2024年5月15日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Male

入选标准

  • 1. Transgender woman who undergone vaginoplasty more than 6 months (inverted penile skin flap technique)
  • 2. Have vaginal symptom (discharge)
  • 3. Can communicate in Thai

排除标准

  • 1. Infected abnormal discharge (fungi, parasite)
  • 2. Vaginal douche within 3 days
  • 3. Sexual intercourse via neovaginal route within 3 days
  • 4. Antibiotic used within 4 weeks
  • 5. Medical drug use via neovagina within 4 weeks
  • 6. Active complication from surgery or last treatment within 6 months
  • 7. Unable to follow up
  • 8. Medical condition (DM, autoimmune disease, HIV, cancer)

研究者

发起方
Ratchadapiseksompotch fund

相似试验

The improvement of neovaginal symptoms and... | 临床试验